Oral Medicine, Oral Surgery and Implantology Unit, MedOralRes Group, University of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS).
Oral and Maxillofacial Pathology and Oral Medicine Unit, Department of Stomatology II, University of the Basque Country, Leioa, Spain.
Appl Immunohistochem Mol Morphol. 2021 Oct 1;29(9):706-712. doi: 10.1097/PAI.0000000000000945.
Bcl-2 is a group of apoptotic proteins that play a key role in cellular homeostasis. Overexpression of Bcl-2 has been associated with the poor prognosis of oral squamous cell carcinoma (OSCC). The aim of this study is to analyze the immunohistochemical expression of Bcl-2 in healthy oral mucosa, different oral potentially malignant disorders and OSCC, and to determine its diagnostic value. A retrospective observational study was carried out in the Oral Medicine Unit of the University of Santiago de Compostela. All the clinicopathologic data were collected and paraffin-embedded blocks were available to perform the immunohistochemistry study with Bcl-2. We studied 18 fibromas, 15 OSCC, 29 oral leukoplakia lesions (OL), 59 oral lichen planus (OLP) cases, and 16 healthy controls. OL with epithelial dysplasia (31.2%) showed the highest expression of Bcl-2 and OLP (1.9%) showed the lowest expression of Bcl-2 (P=0.025). Receiver operating characteristics curves showed that the detection of Bcl-2 enables discrimination between OL and OLPs (sensitivity: 58.6%, specificity of 99.32%). Bcl-2 negative expression in the OLP diagnosis obtained an odds ratio of 13.750 (95% confidence interval: 3.354-56.369; P<0.0001) and the positive expression in the OL 4.468 (95% confidence interval: 1.889-10.565; P=0.001). Bcl-2 could be used as a diagnostic biomarker to study their malignant transformation.
Bcl-2 是一组凋亡蛋白,在细胞稳态中发挥关键作用。Bcl-2 的过表达与口腔鳞状细胞癌(OSCC)的预后不良有关。本研究旨在分析 Bcl-2 在健康口腔黏膜、不同口腔潜在恶性疾病和 OSCC 中的免疫组织化学表达,并确定其诊断价值。这项回顾性观察性研究在圣地亚哥德孔波斯特拉大学口腔医学系进行。收集了所有的临床病理数据,并提供了石蜡包埋块,以进行 Bcl-2 的免疫组织化学研究。我们研究了 18 例纤维瘤、15 例 OSCC、29 例口腔白斑病变(OL)、59 例口腔扁平苔藓(OLP)和 16 例健康对照。具有上皮异型增生的 OL(31.2%)表现出最高的 Bcl-2 表达,而 OLP(1.9%)表现出最低的 Bcl-2 表达(P=0.025)。受试者工作特征曲线显示,Bcl-2 的检测能够区分 OL 和 OLP(敏感性:58.6%,特异性:99.32%)。OLP 诊断中 Bcl-2 阴性表达的优势比为 13.750(95%置信区间:3.354-56.369;P<0.0001),OL 中 Bcl-2 阳性表达的优势比为 4.468(95%置信区间:1.889-10.565;P=0.001)。Bcl-2 可作为研究其恶性转化的诊断生物标志物。